Graphical Abstract
Figure: Concepts of cardiac aging. Abbreviations: E/e’, transmitral early velocity to early diastolic mitral annular velocity; EF, ejection fraction; LV, left ventricular; LVEDD, left ventricular end-diastolic diameter; M/V left, ventricular mass to volume ratio.
In healthy individuals without cardiovascular disease, aging is accompanied by a particular pattern of ‘physiological’ cardiac remodeling [1]. Prior cardiac magnetic resonance (CMR) data on 5004 participants from the MESA (Multi-Ethnic Study of Atherosclerosis) study found that with increasing age, left ventricular (LV) mass, stroke volume, and end-diastolic volumes decline despite a small increase in ejection fraction (EF) [1]. Interestingly, even though LV mass declined, LV mass to volume increased indicating higher LV stiffness. The underlying mechanisms and clinical implications of this remodeling remain elusive as systematic investigations are largely missing, and to this date, evidence was mostly stemming from US population–based cohorts. [1, 2]
In this issue of Clinical Research in Cardiology, Grassow et al. used a German cohort consisting of 140 healthy individuals to study the influence of sex and age on cardiac remodeling with CMR [3]. Individuals with known cardiovascular risk factors or established cardiovascular disease were excluded from the study. Similar to the findings from the MESA study [1], the authors report that with increasing age, LV end-diastolic volume indices as well as LV stroke volume indices decreased in both men and women, while LV mass remained largely unchanged. Again, LV mass-to-volume ratio was observed to increase over time, with men exhibiting a more prominent decline in LV stroke volume compared with women. Right ventricular (RV) end-diastolic volume indices decreased at a similar rate as LV volume indices in both sexes.
In contrast to physiological aging, “pathological” age-related changes in cardiac geometry and function are highly associated with the presence of traditional risk factors such as hypertension and diabetes and specific genetic conditions such as cardiac amyloidosis (Graphical abstract). Elevated LV afterload and uncontrolled hyperglycemia will eventually result in cardiac hypertrophy and cardiac fibrosis and path the way for adverse cardiac remodeling characterized by a decreased LV compliance over time. Subsequently, elevated LV filling pressures predispose to the development of heart failure with preserved ejection fraction (HFpEF) and pulmonary hypertension [2]. Affected individuals are at increased risk of cardiovascular death and predominantly suffer from dyspnea, increased fatigue, and exercise intolerance. [4, 5]
Although in the study by Grassow et al. as well as in other prior studies individuals with the presence of cardiovascular risk factors were excluded, it remains uncertain whether aging itself determines the specific pattern of “physiological” cardiac remodeling over time. In industrialized societies, systolic blood pressure increases with age, and this age-related rise in systolic blood pressure is commonly considered part of “normal” aging societies [6, 7]. However, it is much less pronounced in indigenous societies, suggesting that residual lifestyle and environmental factors may contribute more than widely recognized [8]. A prospective observational study in Tsimane forager-farmers, an indigenous tribe in Bolivia, found that in the absence of an industrialized environment, hypertension is far less prevalent compared to, e.g., US populations. This difference is attributed to a healthy lifestyle characterized by a great amount of physical activity, a predominantly plant-based diet low in sodium, and the absence of overweight or obesity. Acculturation to a Western lifestyle has been shown to result in a steeper relationship between age and systolic blood pressure [9]. Hence, “physiological” age-related cardiac changes likely reflect the cumulative exposure to risk factors during a person’s course of life and probably greatly vary between societies and cultures.
To this date, little is known about age-related sex-specific cardiac changes [10]. Female hearts display smaller chamber sizes, increased left LV wall thickness, and greater diastolic dysfunction [10]. Women are consequently more susceptible to developing HFpEF as compared to males who tend to develop heart failure with reduced ejection fraction (HFrEF) [10,11,12,13]. The reasons for this difference are likely explained by the lifetime course of sex hormones as women after menopause show an abrupt increase in blood pressure (eventually exceeding that of men) [6, 9]. Estrogen has been shown to reduce collagen synthesis in vitro in murine and human cardiac fibroblasts, suggesting that a drop in estrogen levels after menopause may be responsible for increased LV interstitial collagen deposition. [14]
Despite its limitations, the study by Grassow et al. provides us with valuable data on age- and sex-related structural and functional cardiac changes using a middle-European cohort. Clinicians should be aware of these sex- and age-specific differences. Reference values for cardiac geometry and function at older age can be derived which are relevant for daily decision-making on whether certain findings are to be considered physiological or already pathological.
References
Cheng S, Fernandes VR, Bluemke DA, McClelland RL, Kronmal RA, Lima JA (2009) Age-related left ventricular remodeling and associated risk for cardiovascular outcomes: the Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Imaging 2(3):191–198. https://doi.org/10.1161/circimaging.108.819938
Zierath R, Claggett B, Arthur V et al (2023) Changes in pulmonary artery pressure late in life: the atherosclerosis risk in communities (ARIC) study. J Am Coll Cardiol 82(23):2179–2192. https://doi.org/10.1016/j.jacc.2023.09.821
Grassow L, Gröschel J, Saad H et al (2024) Sex-specific structural and functional cardiac remodeling during healthy aging assessed by cardiovascular magnetic resonance. Clin Res Cardiol. https://doi.org/10.1007/s00392-024-02430-5
Choudhary G, Jankowich M, Wu W-C (2014) Elevated pulmonary artery systolic pressure predicts heart failure admissions in African Americans. Circ Heart Fail 7(4):558–564. https://doi.org/10.1161/CIRCHEARTFAILURE.114.001366
Lam CSP, Borlaug BA, Kane GC, Enders FT, Rodeheffer RJ, Redfield MM (2009) Age-associated increases in pulmonary artery systolic pressure in the general population. Circulation 119(20):2663–2670. https://doi.org/10.1161/CIRCULATIONAHA.108.838698
Beaney T, Schutte AE, Tomaszewski M et al (2018) May measurement month 2017: an analysis of blood pressure screening results worldwide. Lancet Glob Health 6(7):e736–e743. https://doi.org/10.1016/S2214-109X(18)30259-6
Franklin SS, Gustin W, Wong ND et al (1997) Hemodynamic patterns of age-related changes in blood pressure. Circulation 96(1):308–315. https://doi.org/10.1161/01.CIR.96.1.308
Gurven M, Blackwell AD, Rodríguez DE, Stieglitz J, Kaplan H (2012) Does blood pressure inevitably rise with age? Hypertension 60(1):25–33. https://doi.org/10.1161/HYPERTENSIONAHA.111.189100
Angeli F, Reboldi G, Verdecchia P (2012) “From Apennines to Andes:” does body mass index affect the relationship between age and blood pressure? Hypertension 60(1):6–7. https://doi.org/10.1161/HYPERTENSIONAHA.112.192534
Ji H, Kwan AC, Chen MT et al (2022) Sex differences in myocardial and vascular aging. Circ Res 130(4):566–577. https://doi.org/10.1161/CIRCRESAHA.121.319902
Cheng S, Xanthakis V, Sullivan LM et al (2010) Correlates of echocardiographic indices of cardiac remodeling over the adult life course. Circulation 122(6):570–578. https://doi.org/10.1161/CIRCULATIONAHA.110.937821
Dunlay SM, Roger VL, Redfield MM (2017) Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol 14(10):591–602. https://doi.org/10.1038/nrcardio.2017.65
Redfield MM, Jacobsen SJ, Borlaug BA, Rodeheffer RJ, Kass DA (2005) Age- and gender-related ventricular-vascular stiffening. Circulation 112(15):2254–2262. https://doi.org/10.1161/CIRCULATIONAHA.105.541078
Dworatzek E, Mahmoodzadeh S, Schriever C et al (2019) Sex-specific regulation of collagen I and III expression by 17β-estradiol in cardiac fibroblasts: role of estrogen receptors. Cardiovasc Res 115(2):315–327
Funding
Open Access funding enabled and organized by Projekt DEAL.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Bernhard Haring and Philipp Markwirth report no conflicts of interest.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Markwirth, P., Haring, B. Age- and sex-specific physiological cardiac remodeling: the search for the Fountain of Youth. Clin Res Cardiol (2024). https://doi.org/10.1007/s00392-024-02431-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00392-024-02431-4